首页|Jianpi Huoxue Decoction Ameliorates Alcohol-associated Liver Disease by Improving Intestinal Barrier Function in Rats

Jianpi Huoxue Decoction Ameliorates Alcohol-associated Liver Disease by Improving Intestinal Barrier Function in Rats

扫码查看
Objective:Jianpi huoxue decoction(JHD),a Chinese herbal formula,is commonly used for treating alcohol-associated liver disease(ALD).This study aimed to investigate the mechanism by which JHD affects intestinal barrier function in ALD rats.Methods:The Sprague-Dawley rats were randomly divided into three groups:control group,model group and JHD group.They were pair-fed a modified Lieber-DeCarli liquid diet containing alcohol(model group,n=10;JHD group,n=10)or isocaloric maltose dextrin(control group,n=10)for 6 weeks.After 3 weeks of feeding,the mice in the JHD group were given JHD(10 mL/kg/day)by gavage for 3 weeks,and those in the control and model groups received equal amounts of double-distilled water for the same period of time.Afterwards,all the rats were given lipopolysaccharide(LPS)by gavage and sacrificed 3.5 h later.LPS levels were measured in the portal blood to evaluate gut leakage.Transmission electron microscopy(TEM)was used to observe ultrastructural changes in the intestinal tract.Adherens junction(AJ)and tight junction(TJ)proteins were detected by Western blotting,immunofluorescence or immunohistochemistry.Results:JHD ameliorated Lieber-DeCarli liquid diet-induced hepatic steatosis,inflammation and LPS expression.It improved pathological changes in the liver and alleviated intestinal ultrastructure injury.Moreover,it significantly enhanced the integrity of tight junctions by increasing the expression of zonula occludens-1(ZO-1)and occludin.It suppressed the activation of myosin light chain(MLC)phosphorylation.Conclusion:JHD improves intestinal barrier function and reduces gut leakiness in ALD rats.

alcohol-associated liver diseaseJianpi Huoxue decoctionintestinal barrier functionintestinal permeabilitytight junctionlipopolysaccharide

Xin WANG、Dong-sheng YAO、Lin XU、Dong-ming YAN、Yu ZHAO、Jing-hua PENG、Qi-lin FU、Yi-yang HU、Qin FENG

展开 >

Institute of Liver Diseases,Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine,Shanghai 201203,China

Shanghai Key Laboratory of Traditional Chinese Clinical Medicine,Shanghai 201203,China

Key Laboratory of Liver and Kidney Diseases,Shanghai University of Traditional Chinese Medicine,Shanghai 201203,China

Clinical Pharmacokinetics Laboratory,Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine,Shanghai 201203,China

展开 >

2024

当代医学科学(英文)
华中科技大学同济医学院

当代医学科学(英文)

影响因子:0.748
ISSN:2096-5230
年,卷(期):2024.44(6)